- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.90 Å
- Oligo State
- homo-hexamer
- Ligands
- 18 x ZN: ZINC ION(Non-covalent)
- 6 x LEU: LEUCINE(Non-covalent)
LEU.4: 13 residues within 4Å:- Chain A: K.250, D.255, K.262, M.270, D.273, D.332, E.334, T.359, L.360, G.362, A.451
- Ligands: ZN.1, ZN.2
4 PLIP interactions:4 interactions with chain A,- Hydrophobic interactions: A:A.451
- Hydrogen bonds: A:K.250
- Salt bridges: A:K.250, A:K.262
LEU.11: 13 residues within 4Å:- Chain B: K.250, D.255, K.262, M.270, D.273, D.332, E.334, T.359, L.360, G.362, A.451
- Ligands: ZN.8, ZN.9
4 PLIP interactions:4 interactions with chain B- Hydrophobic interactions: B:A.451
- Hydrogen bonds: B:K.250
- Salt bridges: B:K.250, B:K.262
LEU.18: 13 residues within 4Å:- Chain C: K.250, D.255, K.262, M.270, D.273, D.332, E.334, T.359, L.360, G.362, A.451
- Ligands: ZN.15, ZN.16
4 PLIP interactions:4 interactions with chain C,- Hydrophobic interactions: C:A.451
- Hydrogen bonds: C:K.250
- Salt bridges: C:K.250, C:K.262
LEU.25: 13 residues within 4Å:- Chain D: K.250, D.255, K.262, M.270, D.273, D.332, E.334, T.359, L.360, G.362, A.451
- Ligands: ZN.22, ZN.23
6 PLIP interactions:6 interactions with chain D,- Hydrophobic interactions: D:A.451
- Hydrogen bonds: D:K.250, D:K.250, D:D.332
- Salt bridges: D:K.250, D:K.262
LEU.32: 13 residues within 4Å:- Chain E: K.250, D.255, K.262, M.270, D.273, D.332, E.334, T.359, L.360, G.362, A.451
- Ligands: ZN.29, ZN.30
4 PLIP interactions:4 interactions with chain E,- Hydrophobic interactions: E:A.451
- Hydrogen bonds: E:K.250
- Salt bridges: E:K.250, E:K.262
LEU.39: 13 residues within 4Å:- Chain F: K.250, D.255, K.262, M.270, D.273, D.332, E.334, T.359, L.360, G.362, A.451
- Ligands: ZN.36, ZN.37
4 PLIP interactions:4 interactions with chain F,- Hydrophobic interactions: F:A.451
- Hydrogen bonds: F:K.250
- Salt bridges: F:K.250, F:K.262
- 18 x MRD: (4R)-2-METHYLPENTANE-2,4-DIOL(Non-functional Binders)
MRD.5: 7 residues within 4Å:- Chain A: A.48, G.49, W.82, E.87, N.88, A.91, P.461
Ligand excluded by PLIPMRD.6: 7 residues within 4Å:- Chain A: L.46, K.50, T.51, R.52
- Chain D: Q.99, D.102, E.104
Ligand excluded by PLIPMRD.7: 7 residues within 4Å:- Chain A: H.233, Y.234, P.244, N.295, I.296, V.297, F.349
Ligand excluded by PLIPMRD.12: 7 residues within 4Å:- Chain B: A.48, G.49, W.82, E.87, N.88, A.91, P.461
Ligand excluded by PLIPMRD.13: 7 residues within 4Å:- Chain B: L.46, K.50, T.51, R.52
- Chain F: Q.99, D.102, E.104
Ligand excluded by PLIPMRD.14: 7 residues within 4Å:- Chain B: H.233, Y.234, P.244, N.295, I.296, V.297, F.349
Ligand excluded by PLIPMRD.19: 7 residues within 4Å:- Chain C: A.48, G.49, W.82, E.87, N.88, A.91, P.461
Ligand excluded by PLIPMRD.20: 7 residues within 4Å:- Chain C: L.46, K.50, T.51, R.52
- Chain E: Q.99, D.102, E.104
Ligand excluded by PLIPMRD.21: 7 residues within 4Å:- Chain C: H.233, Y.234, P.244, N.295, I.296, V.297, F.349
Ligand excluded by PLIPMRD.26: 7 residues within 4Å:- Chain D: A.48, G.49, W.82, E.87, N.88, A.91, P.461
Ligand excluded by PLIPMRD.27: 7 residues within 4Å:- Chain A: Q.99, D.102, E.104
- Chain D: L.46, K.50, T.51, R.52
Ligand excluded by PLIPMRD.28: 7 residues within 4Å:- Chain D: H.233, Y.234, P.244, N.295, I.296, V.297, F.349
Ligand excluded by PLIPMRD.33: 7 residues within 4Å:- Chain E: A.48, G.49, W.82, E.87, N.88, A.91, P.461
Ligand excluded by PLIPMRD.34: 7 residues within 4Å:- Chain C: Q.99, D.102, E.104
- Chain E: L.46, K.50, T.51, R.52
Ligand excluded by PLIPMRD.35: 7 residues within 4Å:- Chain E: H.233, Y.234, P.244, N.295, I.296, V.297, F.349
Ligand excluded by PLIPMRD.40: 7 residues within 4Å:- Chain F: A.48, G.49, W.82, E.87, N.88, A.91, P.461
Ligand excluded by PLIPMRD.41: 7 residues within 4Å:- Chain B: Q.99, D.102, E.104
- Chain F: L.46, K.50, T.51, R.52
Ligand excluded by PLIPMRD.42: 7 residues within 4Å:- Chain F: H.233, Y.234, P.244, N.295, I.296, V.297, F.349
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Strater, N. et al., Two-metal ion mechanism of bovine lens leucine aminopeptidase: active site solvent structure and binding mode of L-leucinal, a gem-diolate transition state analogue, by X-ray crystallography. Biochemistry (1995)
- Release Date
- 1995-10-15
- Peptides
- LEUCINE AMINOPEPTIDASE: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.90 Å
- Oligo State
- homo-hexamer
- Ligands
- 18 x ZN: ZINC ION(Non-covalent)
- 6 x LEU: LEUCINE(Non-covalent)
- 18 x MRD: (4R)-2-METHYLPENTANE-2,4-DIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Strater, N. et al., Two-metal ion mechanism of bovine lens leucine aminopeptidase: active site solvent structure and binding mode of L-leucinal, a gem-diolate transition state analogue, by X-ray crystallography. Biochemistry (1995)
- Release Date
- 1995-10-15
- Peptides
- LEUCINE AMINOPEPTIDASE: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
A